{{Rsnum
|rsid=2289656
|Gene=NTRK2
|Chromosome=9
|position=84948647
|Orientation=minus
|GMAF=0.1281
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=NTRK2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 67.3 | 31.9 | 0.9
| HCB | 89.8 | 10.2 | 0.0
| JPT | 95.6 | 3.5 | 0.9
| YRI | 85.0 | 14.3 | 0.7
| ASW | 82.5 | 14.0 | 3.5
| CHB | 89.8 | 10.2 | 0.0
| CHD | 92.7 | 7.3 | 0.0
| GIH | 83.2 | 14.9 | 2.0
| LWK | 81.7 | 17.4 | 0.9
| MEX | 75.9 | 22.4 | 1.7
| MKK | 69.2 | 27.6 | 3.2
| TSI | 66.7 | 27.5 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19844206
|Title=Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans
|OA=1
}}

{{PMID Auto
|PMID=17212826
|Title=TAMGeS: a Three-array Method for Genotyping of SNPs by a dual-colour approach.
|OA=1
}}

{{PMID Auto
|PMID=18780967
|Title=SNPs in neurotrophin system genes and Alzheimer's disease in an Italian population.
}}

{{PMID Auto
|PMID=19018715
|Title=Association studies of the BDNF and the NTRK2 gene polymorphisms with prophylactic lithium response in bipolar patients.
}}

{{PMID Auto
|PMID=23315174
|Title=Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar I disorder.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}